in this issue
Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Catalent Sells Osny Unit
11:17 AM MDT | April 10, 2009
Catalent Pharma Solutions (Somerset, NJ), a contract manufacturer and pharmaceutical services company, says it has sold its Osny, France oral drug manufacturing business to Bavaria Industriekapital (Munich), a holding company that buys, restructures, and re-sells firms in Europe. Terms were not disclosed. Bavaria Industriekapital expects to retain all employees associated with the purchase and to continue to serve the business’s existing customers, Catalent says. The business will become known as Osny Pharma after the acquisition closes, Catalent says. Osny...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee